Featured research: innovations, safety and evolving pathways in modern TAVI care

Summary

This session addresses contemporary challenges in TAVI, including management of acute valve syndrome through service innovations and the application of Valvosoft non-invasive ultrasound therapy in severe aortic stenosis. It also explores complications such as infective endocarditis post-TAVI, evaluates the feasibility of same-day discharge protocols, and assesses the safety and efficacy of TAVI in patients with bicuspid aortic valve stenosis.

Presentations available when logged in:

  • Addressing acute valve syndrome presentations in an Australian TAVI programme using service innovation
  • Valvosoft non-invasive ultrasound therapy in very severe aortic stenosis: 12-month results
  • Infective endocarditis after TAVI
  • Is same-day discharge of TAVI patients possible?
  • Safety and efficacy of TAVI in bicuspid aortic valve stenosis